In our first set of experiments, we harvested peripheral blood cells and the cell-free plasma from LPS-Stx2 treated mice in which severe HUS was developing, and transferred these components to recipient mice that had no prior Stx2 exposure. Here, STX2 is linked to hemolytic-uremic syndrome.